Citadel Advisors
VIVO

Citadel Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Citadel Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-125,670
Closed -$4.17M – 16159
2022
Q4 		$4.17M Buy
+125,670
New +$4.05M ﹤0.01% 4169
2022
Q2 		– Sell
-45,651
Closed -$1.23M – 14660
2022
Q1 		$1.19M Buy
45,651
+33,670
+281% +$801K ﹤0.01% 7322
2021
Q4 		$244K Sell
11,981
-54,599
-82% -$1.05M ﹤0.01% 11421
2021
Q3 		$1.28M Sell
66,580
-25,618
-28% -$511K ﹤0.01% 7499
2021
Q2 		$2.04M Sell
92,198
-33,486
-27% -$710K ﹤0.01% 6569
2021
Q1 		$3.3M Sell
125,684
-32,115
-20% -$764K ﹤0.01% 5212
2020
Q4 		$2.95M Buy
157,799
+138,350
+711% +$2.58M ﹤0.01% 4614
2020
Q3 		$330K Sell
19,449
-49,372
-72% -$960K ﹤0.01% 7972
2020
Q2 		$1.6M Sell
68,821
-41,569
-38% -$602K ﹤0.01% 4954
2020
Q1 		$927K Buy
110,390
+99,555
+919% +$838K ﹤0.01% 5481
2019
Q4 		$106K Sell
10,835
-78,325
-88% -$735K ﹤0.01% 8524
2019
Q3 		$846K Sell
89,160
-53,201
-37% -$561K ﹤0.01% 5881
2019
Q2 		$1.69M Sell
142,361
-53,611
-27% -$646K ﹤0.01% 4808
2019
Q1 		$3.45M Sell
195,972
-11,066
-5% -$184K ﹤0.01% 3528
2018
Q4 		$3.59M Buy
207,038
+25,632
+14% +$437K ﹤0.01% 3273
2018
Q3 		$2.7M Sell
181,406
-141,909
-44% -$2.2M ﹤0.01% 3895
2018
Q2 		$5.14M Buy
323,315
+271,472
+524% +$4.05M ﹤0.01% 2737
2018
Q1 		$736K Sell
51,843
-10,672
-17% -$158K ﹤0.01% 5256
2017
Q4 		$875K Sell
62,515
-66,364
-51% -$971K ﹤0.01% 4843
2017
Q3 		$1.84M Buy
128,879
+43,598
+51% +$623K ﹤0.01% 3499
2017
Q2 		$1.34M Sell
85,281
-81,045
-49% -$1.17M ﹤0.01% 3681
2017
Q1 		$2.29M Buy
166,326
+97,822
+143% +$1.37M ﹤0.01% 2920
2016
Q4 		$1.21M Sell
68,504
-122,890
-64% -$2.16M ﹤0.01% 3597
2016
Q3 		$3.69M Sell
191,394
-72,589
-27% -$1.42M ﹤0.01% 2285
2016
Q2 		$5.15M Buy
263,983
+134,153
+103% +$2.63M 0.01% 1798
2016
Q1 		$2.68M Buy
129,830
+32,689
+34% +$644K ﹤0.01% 2364
2015
Q4 		$1.99M Buy
97,141
+21,636
+29% +$415K ﹤0.01% 2746
2015
Q3 		$1.29M Sell
75,505
-186,159
-71% -$3.4M ﹤0.01% 3486
2015
Q2 		$4.88M Buy
261,664
+45,588
+21% +$845K ﹤0.01% 2090
2015
Q1 		$4.12M Sell
216,076
-7,674
-3% -$142K ﹤0.01% 2234
2014
Q4 		$3.68M Buy
223,750
+81,602
+57% +$1.4M ﹤0.01% 2265
2014
Q3 		$2.52M Buy
142,148
+58,455
+70% +$1.15M ﹤0.01% 2610
2014
Q2 		$1.73M Sell
83,693
-102,638
-55% -$2.11M ﹤0.01% 2874
2014
Q1 		$4.06M Buy
186,331
+95,412
+105% +$2.19M ﹤0.01% 1966
2013
Q4 		$2.41M Buy
90,919
+16,631
+22% +$409K ﹤0.01% 2355
2013
Q3 		$1.76M Sell
74,288
-7,456
-9% -$174K ﹤0.01% 2538
2013
Q2 		$1.76M Buy
+81,744
New +$1.76M ﹤0.01% 2627

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's VIVO Position: Q1 2023 in Review

Citadel Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 125,670 shares — an estimated $4.17M sold.

Citadel Advisors first reported a position in VIVO in Q2 2013 and held it in 37 quarters. The position peaked at $5.15M in Q2 2016. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Citadel Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 125,670 Meridian Bioscience Inc shares in Q1 2023, an estimated $4.17M.
  • Citadel Advisors first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 37 quarters.
  • Citadel Advisors's Meridian Bioscience Inc position peaked at $5.15M in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.